ICMR Justifies Fast Tracking Letter

The Indian Council of Medical Research (ICMR) released a statement justifying its fast tracking of Bharat Biotech's COVAXIN.The research body said its following globally accepted norms of fast tracking. It also mentions that the expedition process is as per what other companies and governments have followed across the world. The statement however does not mention the August 15 deadline. 

The statement says that the DCGI has granted permission only after studying the available pre-clinical data but this data has not been disclosed in the clinical trial registration.